GLG News by Medical Tourism Experts

A new Health IT bill from no less than Congressman Pete Stark, Chairman of the Health Subcommittee of the U.S. House's powerful Ways and Means Committee aims to provide substantial financial incentives for hospitals and physicians to adopt electronic health records.  The bill also provides disincentives...

Payers in the private sector have historically tried to get providers to pay the generic price for branded multisource products using maximum allowable cost (MAC) terminology in their contracts as soon as the branded drugs have a generic source. This has caused problems for providers that still have...

The Health IT Now Coalition, (comprised of more than 175 business, associations, patient organizations and nonprofit groups), will soon deliver a letter to Congress urging it to act on longstanding bipartisan health IT legislation.  The coalition is pushing for passage of legislation championed...

Health IT has been touted as a necessary component of transformational change for the healthcare industry for quite some time.  But until this past week, no highly respected  body had laid down the standards which health IT must achieve to fulfill its promise.  The National Quality Forum,...

It used to be said that everything good (and bad) in this country started in California.  It seems that at least in health care that dubious honorific may now apply more to Massachusetts. Massachusetts Governor Deval Patrick signed a law last week, which, among other things mandates that hospitals...

The conclusion of this preliminary trial (dose finding study) is that "once daily tadalafil demonstrated clinically meaningful and statistically significant efficacy and it was well tolerated in men with benign prostatic hyperplasia lower urinary tract symptoms", and hence suggesting at least two...

This past week for the first time, the federal government posted on its  Hospital Compare web site the actual death rates for hospitals treating patients with three conditions:  heart attack, heart failure and pneumonia.  In the past, the feds had only indicated whether these death rates...

This article could easily be spun as a victory for stent efficacy.

The "cost" identified in the commentary does not delineate the cost to the pharmaceutical company to produce the drug.  Nor does cost identification differentiate between production, distribution of research and development cost, and profit margin to the company.  There is currently no regulations...

 Transparency adds value by 1) driving knowledge based decision-making 2) building accountability at each decision point and 3) educating consumers  to options and  risks.  In the face of escalating unsustainable cost and the failure of the hospitals to build the infrastructure to...